Thank you, Mr. Chair.
I have a question for the FCCF. Thank you for coming to this committee today.
The regulations use vague terms such as “positive measures”, “vitality” and “negative impacts”, but do not define them. From your perspective, does this lack of precision provide sufficient guidance for federal institutions, and would clear definitions improve consistency?
The question is for anyone.